People: Oxygen Biotherapeutics Inc (OXBT.O)

OXBT.O on Consolidated Issue listed on NASDAQ Capital Market

4.15USD
23 May 2013
Price Change (% chg)

$-0.30 (-6.76%)
Prev Close
$4.45
Open
$4.26
Day's High
$4.35
Day's Low
$4.02
Volume
3,573
Avg. Vol
14,790
52-wk High
$45.00
52-wk Low
$3.60

Search Stocks

Jebsen, Michael 

Brief Biography

Mr. Michael B. Jebsen, CPA, is President, Interim CEO, CFO, EVP - Finance and Administration, Treasurer, Corporate Secretary of Oxygen Biotherapeutics, Inc. He joined Oxygen as Accounting Manager in April 2009, and was elected Chief Financial Officer, Executive Vice President Finance and Administration, and Corporate Secretary in August 2009 and was appointed as Interim Chief Executive Officer on August 24, 2011. Before joining the company, he was an auditor with Grant Thornton, LLP from July 2003 through December 2005 and from April 2008 through April 2009. In addition, he held various positions, including Chief Ethics Officer, Senior Internal Auditor, and Senior Financial Analyst with RTI International, a non-profit research and development organization, from January 2006 to February 2008. Mr. Jebsen holds a Master of Science in Accounting from East Carolina University and is a Certified Public Accountant, licensed in North Carolina.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
295,000 -- 114,600 426,456

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Search Stocks